Cancers of the Head and Neck Terminated Phase 2 Trials for Oxaliplatin (DB00526)

Also known as: Cancer of the Head and Neck

IndicationStatusPhase
DBCOND0065283 (Cancers of the Head and Neck)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00256295Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck CancerTreatment
NCT01370876Efficacy and Safety Study of Oxaliplatin/5-FU in Patients With Recurrent or Metastatic Head and Neck CancerTreatment